Apatorsen

N/A

Report date: 2026/05/20 20:02:01
NME

Base Information

Drug NameApatorsen
Drug Alias NameOGX-427ISIS-306053
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionHeat shock protein beta-1 inhibitors
TargetsHeat shock protein beta-1
Therapy Area/IndicationsArthritis, PsoriaticUrinary Bladder NeoplasmsUrologic Neoplasms +[10] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesPoland +[8] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesThe University Of British Columbia
China Registration ClassN/A

Develop Information

Active CompaniesBritish Columbia Cancer Agency
Inactive CompaniesVancouver Coastal Health Research InstituteAchieve Life Sciences IncHoosier Cancer Research Network +[5] 
Active IndicationsProstatic Neoplasms, Castration-Resistant
Inactive IndicationsArthritis, PsoriaticUrinary Bladder NeoplasmsUrologic Neoplasms +[9] 

Other Information

ATC CodeN/A
Related LinksN/A